$NRXP NEWS OUT: @NRxPharma NRx Pharmaceuticals (Nasdaq:NRXP) Announces Final Clinical Trial Results: Superior Safety Combined with Similar Efficacy in the Trial of NRX-101 Compared to Lurasidone in Suicidal Bipolar Depression https://finance.yahoo.com/news/nrx-pharmaceuticals-nasdaq-nrxp-announces-123000838.html?soc_src=social-sh&soc_trk=tw&tsrc=twtr @YahooFinance $JNJ $BMY $LILY